PMID: 6978135Jan 1, 1982Paper

Clinical features of systemic lupus erythematosus: differences related to race and age of onset

Arthritis and Rheumatism
S P BallouI Kushner

Abstract

We compared the frequency of clinical features of systemic lupus erythematosus (SLE) and determined survival in 113 patients with younger-onset lupus (age less than 55 at clinical diagnosis) and 25 patients with older-onset disease (age greater than or equal to 55 at diagnosis). The most striking difference was in the racial distribution; 59% of the younger patients were black, compared with only 20% of the older-onset patients (P less than 0.001). Major manifestation of lupus (including clinically evident renal disease, central nervous system involvement, cutaneous involvement, and hemocytopenia) occurred with similar frequency in both age groups. Antibodies to DNA were detectable equally often in both groups, but hypocomplementemia was more common in the younger patients. Five-year survival in the younger-onset group (79%) was similar to that of the older-onset group (72%); there was a tendency toward relatively improved survival in patients survival of appropriately matched control populations. Major significant differences in racial distribution included 1) a higher incidence of serositis in older whites and in blacks regardless of age, and 2) more frequent hypocomplementemia in younger patients within both racial groups.

References

May 1, 1979·The American Journal of Medicine·S B BakerJ A Mills
May 1, 1978·Arthritis and Rheumatism·A T Masi, R A Kaslow
Jan 1, 1973·Seminars in Arthritis and Rheumatism·M Siegel, S L Lee
Jan 1, 1955·Journal of Chronic Diseases·M MERRELL, L E SHULMAN
Jun 11, 1959·The New England Journal of Medicine·R P McCOMBS, J F PATTERSON
Dec 28, 1963·JAMA : the Journal of the American Medical Association·L M AXTELL
Jan 11, 1965·JAMA : the Journal of the American Medical Association·R K MADDOCK
Jan 11, 1965·JAMA : the Journal of the American Medical Association·M SIEGEL, M SEELENFREUND

❮ Previous
Next ❯

Citations

Dec 1, 1996·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·S J WalshN F Rothfield
Mar 1, 1989·Clinical Rheumatology·M MaragouP Dantis
Jan 1, 1986·Springer Seminars in Immunopathology·M B Stevens
Mar 1, 1995·Clinical Rheumatology·H M al-Attia, S George
Jan 1, 1986·Irish Journal of Medical Science·M Thomas, B Bresnihan
Dec 30, 2006·Rheumatology International·Melissa PadovanFrancesco Trotta
Oct 12, 2007·Modern Rheumatology·Ken YamajiYoshinari Takasaki
Apr 13, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Sara K TedeschiKaren H Costenbader
Aug 1, 1996·Journal of the American Academy of Dermatology·T T ProvostE Simmons-O'Brien
May 12, 2001·Journal of the American Geriatrics Society·G A HeckmanJ A Denburg
Sep 24, 1998·The New England Journal of Medicine·D E HricikJ R Sedor
Oct 18, 2001·Current Opinion in Rheumatology·J Trager, M M Ward
Dec 1, 1996·Seminars in Arthritis and Rheumatism·A KatzP Langevitz
Jun 17, 2004·Nihon rinsho. Japanese journal of clinical medicine·Masanori Funauchi, Toshiaki Yamagata
Oct 1, 1996·International Journal of Dermatology·W K Jacyk, K J Steenkamp
Oct 1, 1992·American Journal of Reproductive Immunology : AJRI·N M BuchananG R Hughes
Apr 28, 2005·International Journal of Clinical Practice·M SayarliogluM Konice
Aug 1, 1993·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·Z YaoE Albert
Aug 1, 1986·Annals of the Rheumatic Diseases·C W Hutton, P J Maddison
Aug 1, 1986·Annals of the Rheumatic Diseases·H G Taylor, C M Stein
Aug 1, 1987·Annals of the Rheumatic Diseases·J WooP Woo
Oct 1, 1991·Annals of the Rheumatic Diseases·J FontM Ingelmo
Mar 1, 1991·Annals of the Rheumatic Diseases·H W JonesD Vergani
Jun 10, 1995·BMJ : British Medical Journal·A G Wilson, G W Duff
Jun 1, 1992·Postgraduate Medical Journal·I DomenechG R Hughes
Apr 1, 2009·Acta Veterinaria Scandinavica·Helene Hansson-Hamlin, Inger Lilliehöök
Jan 24, 2012·Drugs & Aging·Laurent ArnaudZahir Amoura
Aug 18, 2012·ISRN Rheumatology·Ibrahim A Al-Homood
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·A G WilsonG W Duff
Jan 1, 1992·Scandinavian Journal of Rheumatology·K L Wong
Aug 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A A BakirG Dunea
Dec 11, 2007·Best Practice & Research. Clinical Rheumatology·Jennifer K King, Bevra H Hahn
Jun 27, 2006·International Journal of Dermatology·W K Jacyk, K N Bhana
May 18, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Atsushi TakahashiHiromasa Ohira
Oct 1, 1991·The American Journal of Medicine·M PetriM Hochberg
Jun 11, 2004·Seminars in Arthritis and Rheumatism·Diana GómezJuan-Manuel Anaya
Jun 1, 1993·Baillière's Clinical Rheumatology·S P Newman
Feb 1, 1995·Baillière's Clinical Rheumatology·G M Mody

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.